Seer IncSEER
▲ PositiveCapitalrelevance
CEO submits buyout proposal at $2.45/share plus CVRs, driving stock up 26%
Impact on stocks 1
Biotech & Genomic Medicine
Seer IncSeer shares jumped 26% premarket on Monday after the life science firm said it received an unsolicited, non-binding proposal from its CEO Omid Farokhzad to acquire all outstanding shares of Seer’s Class A common stock for $2.45 per share in cash plus two separate contingent value rights. Seer’s board of directors will establish a special committee consisting solely of independent directors to review the proposal.
Seer IncCEO submits buyout proposal at $2.45/share plus CVRs, driving stock up 26%